Columbia University Developmental Therapeutics Program: Striving for Excellence
|
Columbia University / Julia Glade Bender, MD |
Phase I/II Infrastructure Grants |
2013 |
New York |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Defining the Mechanism by which LIN28B acts as an Oncogene in Neuroblastoma |
Children’s Hospital of Philadelphia / Robert Schnepp, MD, PhD |
Young Investigator Grants |
2013 |
Pennsylvania |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |
Develop a Therapeutic Vaccine Approach by Removing Viral Immune Evasion |
University of California, Los Angeles / Ren Sun, PhD |
Springboard Grants |
2013 |
California |
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver / Doug Graham, MD, PhD |
Reach Grants |
2013 |
Colorado |
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD, PhD |
Reach Grants |
2013 |
Michigan |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements |
University of Cincinnati College of Medicine / Jianjun Chen, PhD |
Innovation Grants |
2013 |
Ohio |
DICER1, MicroRNAs and Pediatric Cancer: An Emerging Story |
Research Institute of the McGill University Health Centre / William Foulkes, MD, PhD |
Innovation Grants |
2013 |
Quebec |
Dissecting and Targeting the Wnt Signaling Pathway in Metastatic Osteosarcoma |
Baylor College of Medicine / Jason T. Yustein, MD, PhD |
Young Investigator Grants |
2013 |
Texas |